Pharming (PHAR) Assets Average (2023 - 2025)

Pharming's Assets Average history spans 3 years, with the latest figure at $1.7 billion for Q4 2025.

  • Quarterly results put Assets Average at $1.7 billion for Q4 2025, up 2.85% from a year ago — trailing twelve months through Dec 2025 was $1.7 billion (up 2.85% YoY), and the annual figure for FY2025 was $450.0 million, up 4.3%.
  • Assets Average for Q4 2025 was $1.7 billion at Pharming, up from $1.7 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.7 billion in Q4 2025 to a low of $1.6 billion in Q4 2023.
  • The 3-year median for Assets Average is $1.7 billion (2024), against an average of $1.7 billion.
  • The sharpest move saw Assets Average rose 6.43% in 2024, then grew 2.85% in 2025.
  • Year by year, Assets Average stood at $1.6 billion in 2023, then increased by 6.43% to $1.7 billion in 2024, then grew by 2.85% to $1.7 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.7 billion, $1.7 billion, and $1.6 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.